Response to bevacizumab combination chemotherapy of malignant pleural effusions associated with non-squamous non-small-cell lung cancer

Malignant pleural effusion (MPE) is a common complication of lung cancer with devastating consequences. Since vascular endothelial growth factor (VEGF) has been implicated in MPE, we hypothesized that bevacizumab, an anti-VEGF antibody, may be effective against MPE in patients with non-small-cell lu...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Clin Oncol
Hlavní autoři: MASAGO, KATSUHIRO, FUJIMOTO, DAICHI, FUJITA, SHIRO, HATA, AKITO, KAJI, REIKO, OHTSUKA, KYOKO, OKUDA, CHIYUKI, TAKESHITA, JUMPEI, KATAKAMI, NOBUYUKI
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2015
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4360875/
https://ncbi.nlm.nih.gov/pubmed/25798278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2014.457
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky